INTC vs SCNI · rev $29.70B vs P/E 0.2, rev $1.3M
Intel Corporation (INTC) versus Scinai Immunotherapeutics Ltd (SCNI) — a side-by-side from cached financials, not a winner call.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Latest reported INTC revenue for 2026-06-27 was $29.70B. Net income was -$14.76B. INTC currently screens at market cap $498.43B.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
INTC currently screens at market cap $498.43B. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Not investment advice. Open the INTC and SCNI stock pages for the full models.
Not investment advice.